Panacea Financial Statements From 2010 to 2025
| PLSH Stock | USD 0.05 0.01 9.09% |
Check Panacea Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Panacea Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Panacea financial statements analysis is a perfect complement when working with Panacea Life Valuation or Volatility modules.
Panacea |
Panacea Life Sciences OTC Stock Return On Equity Analysis
Panacea Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Panacea Life Return On Equity | -2.4 |
Most of Panacea Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Panacea Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Panacea Life Sciences has a Return On Equity of -2.3954. This is 90.01% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Panacea Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Panacea Life's current stock value. Our valuation model uses many indicators to compare Panacea Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Panacea Life competition to find correlations between indicators driving Panacea Life's intrinsic value. More Info.Panacea Life Sciences is regarded second in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Panacea Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Panacea Life's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Panacea Life Financial Statements
Investors use fundamental indicators, such as Panacea Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Panacea Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado. Panacea Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 29 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Panacea OTC Stock
Panacea Life financial ratios help investors to determine whether Panacea OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panacea with respect to the benefits of owning Panacea Life security.